Gerberding Julie L. insider trades
Gerberding Julie L. has filed 11 Form 4s with the SEC that we hold, for HLVX (Director), Mckesson Corp (MCK) (Director), Merck & Co., Inc. (MRK) (EVP, Chief Patient Officer) and CERN (Director). Across all of them we count 0 purchases worth $0 and 1 sale worth $8.5M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 96,270 shares of Merck & Co., Inc. worth $8.5M, dated 2021-11-01. The first filing on our record is dated 2021-11-03 and the latest 2026-07-23.
HLVX
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Mckesson Corp (MCK)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Merck & Co., Inc. (MRK)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-11-01 | S, sale reported on Form 4 | 96,270 | $8.5M | 2021-11-03 |
CERN
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1628884) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms